Skip to main content
FinSpry Logo
FinSpry
NEO logo
NEO
(NASDAQ)
NeoGenomics, Inc.
$14.24-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeoGenomics (NEO) Stock Price & Financial Analysis

NeoGenomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.66 - $14.65
52-Week High$15.57
52-Week Low$4.72
Open$13.66
Volume1.90M
Average Volume (3M)3.61M
Market Cap1.84B
Shares Outstanding129.17M
Price to Sales (P/S)2.47
Price to Book (P/B)2.22
EV/EBITDA-59.70
Revenue (TTM)745.97M
Net Income (TTM)-99.21M
Free Cash Flow (TTM)-5.09M
EPS (TTM)$-0.96
Profit Margin-13.30%
Operating Margin-11.26%
Return on Equity (ROE)-11.97%
Debt to Equity0.42
50-Day MA$11.88
200-Day MA$10.68
52-Week Change115.43%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 17, 2020

Frequently Asked Questions About NeoGenomics

What is the current stock price for NEO?

As of the latest trading session, NEO stock trades at $14.24. The 52-week range is $4.72–$15.57, with a day range of $13.66–$14.65.

What is the P/E ratio for NEO?

The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.

Does NEO pay dividends?

NeoGenomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NEO?

Based on 12 analysts, the consensus for NEO is Buy.

What is the market cap of NEO?

NeoGenomics's market capitalization is $1.84B, classifying it as a small-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.